[Optimal adjuvant hormone therapy in postmenopausal women with hormone-sensitive mammary carcinoma: tamoxifen and the aromatase inhibitors anastrozole, exemestane and letrozole].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples